A revolutionary discovery in the field of gerontology shocked the scientific community. A group of scientists has developed a drug that can significantly increase the lifespan of laboratory animals. This achievement could mark a turning point in the fight against aging. The researchers focused on the protein interleukin-11, known for its connection with accelerated aging processes. The developed drug blocks the action of this protein, which leads to impressive results. The treated rats experienced significant improvements in overall health: a reduced risk of developing cancer, and improved hair quality, vision, and muscle function. The most striking result was an increase in the life expectancy of experimental animals by a quarter. Rats treated with the new drug lived an average of 155 weeks, while their relatives in the control group lived only 120 weeks. This significant difference clearly demonstrates the potential of the developed drug. Professor Stuart Cook, one of the study’s co-authors, noted that the treated rats showed noticeably fewer signs of aging and frailty. Moreover, they experienced an increase in muscle strength, which is an important indicator of the overall health of the body. The researchers did not limit themselves to just blocking interleukin-11. They also conducted experiments with genetically modified rats that had the gene responsible for producing IL-11 removed. This approach resulted in a 20% increase in life expectancy. However, the most impressive results were obtained precisely when using a drug that blocks the action of IL-11. Importantly, the treatment also had a positive effect on telomeres, structures at the ends of chromosomes that play a key role in the aging process and the development of age-related diseases. The slowdown in telomere shortening is another confirmation of the effectiveness of the developed drug. The post New anti-aging drug successfully tested on rats appeared first on Anomalien.com.